prostap 3, 11.25 mg, powder and solvent for prolon
takeda uk limited - leuprorelin acetate - pdr+solv for susp for inj - 11.25 milligram
prostap sr 3.75 mg powder and solvent for prolonge
takeda uk limited - leuprorelin acetate - pdr+solv for susp for inj - 3.75 milligram
prostap 3, 11.25 mg, powder and solvent for prolon 11.25 milligram pdr+solv for susp for inj
takeda uk limited - leuprorelin acetate - pdr+solv for susp for inj - 11.25 milligram
prostap sr 3.75 mg powder and solvent for prolonge 3.75 milligram pdr+solv for susp for inj
takeda uk limited - leuprorelin acetate - pdr+solv for susp for inj - 3.75 milligram
xefo 8mg powder and solvent for solution for injec 8 milligram pdr+solv for soln for inf
takeda uk limited - lornoxicam - pdr+solv for soln for inf - 8 milligram
sulfat de atropina takeda 1 mg/ml
takeda austria gmbh - austria - atropinum - sol. inj. - 1mg/ml - belladonna si derivati alcaloizi din belladonna, amine tertiare
calciu d3 takeda 500 mg/200 ui
takeda as - norvegia - combinatii - compr. mast. - 500mg/200ui - calcium calciu in combinatii cu alte medicamente
dexlansoprazol takeda 60 mg hartkapseln mit veränderter wirkstofffreisetzung
takeda pharma a/s (bs 1) (3352751) - dexlansoprazol - hartkapsel mit veränderter wirkstofffreisetzung - teil 1 - hartkapsel mit veränderter wirkstofffreisetzung; dexlansoprazol (32805) 60 milligramm
dexlansoprazol takeda 30 mg hartkapseln mit veränderter wirkstofffreisetzung
takeda pharma a/s (bs 1) (3352751) - dexlansoprazol - hartkapsel mit veränderter wirkstofffreisetzung - teil 1 - hartkapsel mit veränderter wirkstofffreisetzung; dexlansoprazol (32805) 30 milligramm
mesalazine 1.2 takeda (mesalazine) 1.2 g prolonged release tablet blister pack
takeda pharmaceuticals australia pty ltd - mesalazine, quantity: 1200 mg - tablet, modified release - excipient ingredients: methacrylic acid copolymer; purified talc; silicon dioxide; sodium starch glycollate; stearic acid; iron oxide red; carmellose sodium; carnauba wax; magnesium stearate; titanium dioxide; macrogol 6000; triethyl citrate - for the induction and maintenance of remission in patients with mild to moderate, active ulcerative colitis.